Testing a new language and memory test in Belgium
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study checks if a new test for language and memory works well for Dutch-speaking adults in Belgium, including people with multiple sclerosis (MS). The results could help doctors better understand and support thinking skills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak Dutch as your first language
- You can see well enough to look at pictures or words on a screen
- You can use at least one hand to tap or point at answers
- You can understand and follow simple instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to improve memory and learning in people with multiple sclerosis who have mild memory problems. You'll undergo memory training and assessments to see if it helps.
This study tests a program of physical and mental exercises designed to slow down memory and thinking problems in people with multiple sclerosis, and help them stay employed longer.
This study checks how well certain questionnaire and testing tools work for people who have brain damage from neurologic conditions and ongoing brain inflammation. It may help future patients by improving which tests are most accurate and easy to use.
This study looks at how multiple sclerosis affects thinking, energy, mood, and behavior. It uses simple tests and questionnaires to understand your unique profile, which may help tailor future care.
This study tests whether a computer-based cognitive training program is helpful and practical for people with multiple sclerosis who live in the community. It focuses on those who have some memory or learning difficulties.
This study adapts a verbal memory test for deaf adults who use French Sign Language. It aims to make cognitive testing fair and accessible for deaf people.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.